HELIX DIAGNOSTICS
Pharmacogenomics (PGx) Fluoropyrimidines DPYD Test
Test Description
Coming Soon in June 2025
This test evaluates 1 gene associated with response to certain medications including fluoropyrimidines. Results from this test may help in predicting treatment efficacy and risk of side effects for these drugs.
Genes Tested (1)
DPYD
Important Test Information
Turnaround time: 7-10 days
Preferred specimen: BD Vacutainer Whole Blood K2 EDTA Collection Tube 4mL or Oragene Dx Saliva Collection Kit
Shipping Instructions: Specimens to arrive at Helix within 96 hours of collection at ambient temperature.
Cancer and other conditions
All detected variants are evaluated according to the Clinical Pharmacogenetics Implementation Consortium (CPIC). Variants are classified based on known, predicted, or possible impact on drug metabolism.